Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Wuhan Tian'an Pharmaceutical Technology is a pharmaceutical company headquartered in Wuhan, China, specializing in the development and production of traditional Chinese medicines (TCM) and health supplements. The company is primarily recognized for its focus on metabolic health, particularly its Tian'an brand products designed for blood sugar regulation and diabetes support. Operating out of the Wuhan East Lake High-tech Development Zone (Biolake), the firm integrates research and development with modern manufacturing processes to produce botanical-based therapies. Its business scope includes the research of pharmaceutical technologies, the production of health foods, and the distribution of proprietary medicinal formulations. The company serves a significant role in the regional biotech ecosystem, contributing to the modernization of traditional herbal treatments. Their products are widely distributed within the Chinese domestic market, targeting chronic condition management through natural and integrative approaches.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Wuhan Tian'an Pharmaceutical Technology.